NEW YORK (GenomeWeb News) — Shares in Ciphergen were down 10.91 percent, or $.12, at $.98 in mid-afternoon trading today after the company said it finished exchanging $27.5 million worth of outstanding debt for a new series of notes worth $16.5 million, plus cash.

Ciphergen said it finished the exchange of 4.5-percent senior notes due 2008 for a new series of 7-percent convertible senior notes due 2011, together with $11 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.